New study reveals drug levels in breast milk
NCT ID NCT06720714
First seen Apr 25, 2026 · Last updated Apr 25, 2026
Summary
This study looked at how much of the drug rozanolixizumab appears in breast milk after a single dose. Fifteen healthy women who were already planning to stop breastfeeding took part. Researchers collected milk samples over 7 days to measure drug levels and estimate how much a baby might receive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UP0141 1
Salt Lake City, Utah, 84124, United States
-
UP0141 2
San Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.